clinical trials

By Heather Mack December 16, 2016
Patients and their caregivers are playing increasingly prominent roles in research and healthcare technology innovation. As with any emerging shift in healthcare, creating the right foundation to facilitate more robust, inclusive and insightful research comes with challenges, which is where the National Patient Powered Research Network (PPRN) comes in.  “Recruitment into registries and clinical...
By Heather Mack November 7, 2016
Pharmaceutical company Takeda is looking to up its digital strategy game, pairing with a few companies to advance clinical trials, analyze data and develop biosensor and wearable technology. Takeda has adopted the platform of Koneska Health, an early stage technology company that works with data gathered through mobile, wearable and other digital technologies to measure health indicators, to...
By Jonah Comstock October 18, 2016
Kayentis, a French technology company creating data collection and patient engagement tools for clinical trials, has raised $3.9 million (3.6 million euros) in a funding round led by Innovation Capital. Existing investors Extens, Lenapart, and KCE also contributed to the round. The seven-year-old company specializes in electronic clinical outcome assessments (eCOA solutions). That includes...
By Jonah Comstock September 22, 2016
According to a new survey by Validic of 166 executives at pharma and biotech companies, contract research organizations, and others in the clinical trial space, 64 percent have used digital technologies in clinical trials, and 97 percent plan to in the next five years. The survey was presented at DPharm Disruptive Innovations US in Boston. "The use of digital health technologies and patient-...
By Jonah Comstock September 20, 2016
If you were to make a list of companies you'd expect to see at a clinical trial-focused health technology conference like DPharm Disruptive Innovation US, you probably wouldn't include ridesharing companies Uber and Lyft. But they were both in attendance in Boston today, presenting remarkably similar visions for using their software platforms to solve transportation problems in healthcare. "Why...
By Jonah Comstock September 19, 2016
Can the success of digital health coaching apps like Twine Health and WellDoc be ported over to the clinical trial space? According to Joris Van Dam, a strategic projects leader in pharmaceutical development at Novartis, it can and it should. Van Dam spoke at the Mobile in Clinical Trials event today, put on by The Conference Forum.  "The use [of coaching in clinical trials] is a natural fit," he...
By Heather Mack August 1, 2016
Pennsylvania-based CRF Health, provider of electronic clinical outcome assessment solutions (eCOA) for clinical trials, has acquired pioneering digital health company Entra Health for an undisclosed amount. The acquisition will expand CRF’s offerings into the mobile and wireless medical device sector, helping to establish the global company’s network of solutions to collect, manage and analyze...
By Jonah Comstock May 26, 2016
Waltham, Massachusetts-based emotions analytics company Affectiva has raised $14 million in a round led by Fenox Venture Capital. The company intends to use the funding to continue to develop their Emotion AI platform and expand their operations globally. In addition to the funding, the company announced a leadership change, with former CEO and president Nicholas Langeveld becoming chairman of...
By Jonah Comstock May 23, 2016
NeuroCog Trials has received a $1.4 million grant from the National Institute of Aging, a part of the National Institutes of Health, to develop its iPad-based screening tool for clinical trials.  Durham, North Carolina-based NeuroCog Trials has created an iPad app version of the Brief Assessment of Cognition (BAC), a standardized test for cognitive impairment. Doing the BAC on a tablet rather...
By MHN Staff April 8, 2016
More and more, pharma companies are making real bets in digital health, and reorganizing their businesses to put some power behind those efforts. The space is, in some ways, quieter than it was this time last year, but there’s reason to believe that quiet is a calm before a storm of activity, driven more by pharma’s tendency to keep early-stage projects close to the chest than by a lack of...